Edition:
United States

GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

35.22USD
20 Nov 2017
Change (% chg)

$0.16 (+0.44%)
Prev Close
$35.06
Open
$35.21
Day's High
$35.26
Day's Low
$35.16
Volume
729,920
Avg. Vol
3,998,399
52-wk High
$44.53
52-wk Low
$34.72

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.68 December 20 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 3 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 10,040.70 10,407.90 9,700.13 9,528.40
Quarter Ending Mar-18 1 10,602.10 10,602.10 10,602.10 --
Year Ending Dec-17 5 39,904.00 40,602.30 39,366.30 36,544.20
Year Ending Dec-18 5 40,520.20 42,421.80 39,703.90 37,665.70
Earnings (per share)
Quarter Ending Dec-17 1 0.68 0.68 0.68 --
Year Ending Dec-17 4 2.91 2.93 2.87 2.75
Year Ending Dec-18 5 2.81 2.90 2.72 2.71
LT Growth Rate (%) 1 9.00 9.00 9.00 11.75

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 10,354.20 10,258.60 95.51 0.92
Quarter Ending Jun-17 9,527.30 9,365.71 161.58 1.70
Quarter Ending Mar-17 9,399.24 9,230.00 169.24 1.80
Quarter Ending Dec-16 9,310.90 9,414.23 103.32 1.11
Quarter Ending Sep-16 9,184.95 9,928.91 743.96 8.10
Earnings (per share)
Quarter Ending Sep-17 0.83 0.85 0.02 2.41
Quarter Ending Jun-17 0.69 0.70 0.01 2.19
Quarter Ending Mar-17 0.63 0.63 0.00 0.00
Quarter Ending Dec-16 0.64 0.65 0.01 1.56
Quarter Ending Sep-16 0.74 0.85 0.11 14.86

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 10,040.70 10,040.70 10,018.90 10,084.10 9,528.40
Quarter Ending Mar-18 10,602.10 10,602.10 10,602.10 10,602.10 --
Year Ending Dec-17 39,904.00 39,904.00 39,831.30 39,968.80 36,544.20
Year Ending Dec-18 40,520.20 40,520.20 40,739.50 40,739.50 37,665.70
Earnings (per share)
Quarter Ending Dec-17 0.68 0.68 0.74 0.74 --
Year Ending Dec-17 2.91 2.91 2.87 2.87 2.75
Year Ending Dec-18 2.81 2.81 2.87 2.87 2.71

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 2
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 3 1
Year Ending Dec-18 0 0 1 3
Earnings
Quarter Ending Dec-17 0 0 0 1
Year Ending Dec-17 0 0 2 1
Year Ending Dec-18 0 0 0 3